Abstract
Radiopharmaceutical therapy using α-particle emitting radionuclides (αRPT) is a novel treatment modality that delivers highly potent alpha-particles to cancer cells or their environment. We review the advantages and challenges of imaging and dosimetry in implementing αRPT for cancer patients.
Original language | English (US) |
---|---|
Pages (from-to) | 18-29 |
Number of pages | 12 |
Journal | European Journal of Nuclear Medicine and Molecular Imaging |
Volume | 49 |
Issue number | 1 |
DOIs | |
State | Published - Dec 2021 |
Keywords
- Alpha-particle emitter
- Black box
- Dosimetry
- Radiopharmaceutical therapeutics
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging